Fig. 5.
DHA metabolites by LOX protected mouse glomeruli from hHcys-induced dysfunction and injury. A: Summarized data showing the urinary protein from mice with different genotypes and treatments (n = 7). B: Summarized data showing the urinary albumin from mice with different genotypes and treatments (n = 7). C: Images showing the glomerular collagen deposition (picrosirius red staining) from mice with different genotypes and treatments (n = 6). D: Representative images and summarized data of the glomerular morphological changes (periodic acid-Schiff staining) from mice with different genotypes and treatments (n = 6). E: Representative images showing immunostained glomeruli for podocin from mice with different genotypes and treatments (n = 6). F: Representative images showing immunostained glomeruli for desmin from mice with different genotypes and treatments (n = 6). *P < 0.05 versus WT-ND-Vehl group, #P < 0.05 versus WT-FF-Vehl group, $P < 0.05 versus WT-FF-DHA group. Vehl, vehicle.